Structural and Redox Behavior of OxyVita™, a Zero-linked Polymeric Hemoglobin: Comparison with Natural Acellular Polymeric Hemoglobins
- 1 January 2010
- journal article
- research article
- Published by Taylor & Francis in Artificial Cells, Blood Substitutes, and Biotechnology
- Vol. 38 (2) , 64-68
Abstract
A zero-linked polymeric hemoglobin (OxyVita Hb) has been developed for application as an acellular therapeutic hemoglobin-based-oxygen-carrier (HBOC). For effective and safe oxygen binding, transport and delivery, an HBOC must meet essential molecular requirements related to its structural integrity and redox stability. OxyVita™ is a super polymer possessing an average M.wt. of 17 × 106 Da. Structural integrity was determined by unfolding studies of OxyVita™ in the presence of increasing concentrations of urea. The unfolding midpoints (D1/2) of different preparations of OxyVita™ (solution and powder forms) were compared to Lumbricus Hb (LtHb) and Arenicola Hb (ArHb), natural acellular polymeric hemoglobins, which are serving as models for an effective and safe acellular HBOC. Reduction studies of OxyVita Hb using endogenous reducing agents were also investigated. Results from these studies indicate that: 1) OxyVita Hb exhibits greater resistance to conformational change than either LtHb or ArHb in the reduced (oxyHb) state; and 2) the reduction of met OxyVita Hb to oxyHb occurs slowly in the presence of either ascorbic acid (70% reduction in 560 min.) or β-NADH (40% reduction in 90 min.). These studies provide consistent evidence that OxyVita Hb possesses physiochemical properties that exhibit structural integrity and redox behavior necessary for functioning as an effective and safe HBOC within clinical applications. These results are in agreement with observations made by other investigators as to the reduction in heme-loss of OxyVita Hb, essential for the reversible binding/release of molecular oxygen within the circulatory system.Keywords
This publication has 11 references indexed in Scilit:
- Effects of cross-linking and zero-link polymerization on oxygen transport and redox chemistry of bovine hemoglobinBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2009
- Peroxidase activity of hemoglobin towards ascorbate and urate: A synergistic protective strategy against toxicity of Hemoglobin-Based Oxygen Carriers (HBOC)Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2008
- Development of Zero-Link Polymers of Hemoglobin, Which do not Extravasate and do not Induce Pressure Increases upon InfusionArtificial Cells, Blood Substitutes, and Biotechnology, 2007
- Acellular Invertebrate Hemoglobins as Model Therapeutic Oxygen Carriers: Unique Redox PotentialsArtificial Cells, Blood Substitutes, and Biotechnology, 2007
- Vascular response to infusions of a nonextravasating hemoglobin polymerJournal of Applied Physiology, 2002
- Redox Concerns in the use of Acellular Hemoglobin-Based Therapeutic Oxygen Carriers: The Role of Plasma ComponentsArtificial Cells, Blood Substitutes, and Biotechnology, 2000
- Alteration of Redox Stability of Hemoglobins A and S by Biological BuffersComparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 1998
- Zero-link Polymerization: a New Class of Polymeric Hemoglobins1998
- Production and characteristics of an infusible oxygen-carrying fluid based on hemoglobin intramolecularly cross-linked with sebacic acidJournal of Laboratory and Clinical Medicine, 1996
- Hemoglobin and free radicals: implications for the development of a safe blood substituteMolecular Medicine Today, 1995